Malaysia vs Singapore: Proportion of isolates with decreased susceptibility or resistance
Malaysia
6.8
in 2020
Singapore
2.2
in 2020
Malaysia rank
3rd
Singapore rank
6th
Proportion of isolates with decreased susceptibility or resistance over time
- Malaysia
- Singapore
How they compare
Malaysia currently reports 6.8 against 2.2 in Singapore, a difference of 4.6.
That makes Malaysia's figure about 3.1 times Singapore's.
The two have swapped places 1 time across 5 shared years of data; in 2009 it was Singapore ahead.
Malaysia ranks 3rd and Singapore ranks 6th of 52 countries.
Across the 3 decades both report, Malaysia averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Malaysia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 1.25 | 1.25 | Singapore |
| 2010s | 6.05 | 2.22 | 3.83 | Malaysia |
| 2020s | 6.8 | 2.2 | 4.6 | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Malaysia or Singapore?
- Malaysia, at 6.8 against 2.2 in Singapore as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Malaysia and Singapore?
- 4.6, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Singapore?
- 5 years are reported by both, from 2009 to 2020.
- How do Malaysia and Singapore rank globally for proportion of isolates with decreased susceptibility or resistance?
- Malaysia ranks 3rd and Singapore ranks 6th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.